DUBLIN--(BUSINESS WIRE)--The "Global Obstetrics Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
The Global Obstetrics Partnering 2012-2018: Deal trends, players and financials report provides an understanding and access to the Obstetrics partnering deals and agreements entered into by the worlds leading healthcare companies.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Obstetrics disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Obstetrics deals.
The report presents financial deal terms values for Obstetrics deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
Report scope
- Trends in Obstetrics dealmaking in the biopharma industry since 2012
- Analysis of Obstetrics deal structure
- Access to headline, upfront, milestone and royalty data
- The leading Obstetrics deals by value since 2012
Available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in Obstetrics dealmaking
Chapter 3 - Financial deal terms for Obstetrics partnering
Chapter 4 - Leading Obstetrics deals and dealmakers
Chapter 5 - Obstetrics contract document directory
Chapter 6 - Obstetrics dealmaking by therapeutic target
For more information about this report visit https://www.researchandmarkets.com/research/djj88n/global_obstetrics?w=4
